Company news

Imagion Biosystems Ltd. news in 2019

Imagion Biosystems Ltd.'s news releases, calls and decks from 2019, newest first.

View company

Response to ASX price query

December 31, 2019

Completion of Renounceable Rights Issue

November 21, 2019

Pro-Rata Renounceable Rights Issue - Amended Timetable

October 28, 2019

Investor Presentation

September 8, 2019

Appendix 4D and Half Year Report

August 29, 2019

Imagion Biosystems receives A$2 million in R&D tax incentive

July 24, 2019

FDA Breakthrough Device Designation

July 18, 2019

Imagion Biosystems successfully completes toxicology study

May 22, 2019

Imagion Biosystems receives R&D Advanced Overseas Finding

May 13, 2019

IBX receives order related to cancer treatment

April 10, 2019

IBX receives US patent related to treatment of disease

March 11, 2019

FY2018 Appendix 4E and Preliminary Report

February 28, 2019

Decks in 2019